RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @drdargaray: Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @drdargaray: Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca…
RT @drdargaray: Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @drdargaray: Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @drdargaray: Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
Muy buen hilo de @j_alvarezgarcia sobre la importancia de calcular el riesgo de descompensaciones en insuficiencia cardíaca. Felicidades al grupo español que genera esta gran herramienta! #RedinSCORE @smexcardiologia @paomorejon @DanielSierraMD8 @cardiod
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
RT @j_alvarezgarcia: (1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo…
(1)🧐Una de las conclusiones del #VICTORIA trial es la importancia de detectar a los pacientes con #ICFEr y alto riesgo de descompensaciones (ingreso reciente, necesidad de diurético endovenoso, clase NYHA III) https://t.co/m3Yjt6VdOT https://t.co/Odx4MQYR
RT @HeartFailureFrm: One in six patients with #HeartFailure (HF) with reduced ejection fraction develop worsening HF within 18 months of HF…
RT @HeartFailureFrm: One in six patients with #HeartFailure (HF) with reduced ejection fraction develop worsening HF within 18 months of HF…
One in six patients with #HeartFailure (HF) with reduced ejection fraction develop worsening HF within 18 months of HF diagnosis, and have a high risk for 2-year mortality and recurrent HF hospitalisations https://t.co/nEG179hPMG | J Am Coll Cardiol #HFrEF
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. https://t.co/yZnWwujAVq
More evidence documenting miserable use of GDMT for Heart Failure. There can't be this many patients who don't tolerate therapy. What are we doing wrong? Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction https://t.co
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new #JACC study: https:…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new #JACC study: https:…
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction https://t.co/SiKQTu5SJD
Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new #JACC study: https://t.co/s4HMfI593t @JavedButler1 https://t.co/k1IuuJHzme
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. https://t.co/yZnWwujAVq
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @mvaduganathan: Important study by @JavedButler1 et al. from #NCDR PINNACLE showing suboptimal GDMT use & dosing before & after worsenin…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
RT @JACCJournals: Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co…
Standard care therapy use before and after worsening HF in #HFrEF patients is shockingly low says new study: https://t.co/ECRrJ5CSbL #JACC @JavedButler1 https://t.co/3aPztjjOd8
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
Optimize standard medical therapy in #HRrEF patients. Betablocker, ACE/ARB, MRA at target dose will decrease HF hospitalizations and mortality risk.
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis. Imp study in @JACCJournals by @JavedButler1. Surely we can do better for our patients. Critical area we can and need to improve. @ajaysmd @jtheywood @RajeevCMohan @ScrippsCVFellow
RT @mvaduganathan: Important study by @JavedButler1 et al. from #NCDR PINNACLE showing suboptimal GDMT use & dosing before & after worsenin…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
RT @JACCJournals: 1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 htt…
1 in 6 #HFrEF patients develop worsened HF within 18 months of diagnosis: https://t.co/mRWz6U6uKt #JACC @JavedButler1 https://t.co/1zsqmOQi6o
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @mvaduganathan: Important study by @JavedButler1 et al. from #NCDR PINNACLE showing suboptimal GDMT use & dosing before & after worsenin…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
gaps in #heartfailure treatment- opportunities for improved prescription of GDMT https://t.co/tGg6dFR7HQ
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @mvaduganathan: Important study by @JavedButler1 et al. from #NCDR PINNACLE showing suboptimal GDMT use & dosing before & after worsenin…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @mvaduganathan: Important study by @JavedButler1 et al. from #NCDR PINNACLE showing suboptimal GDMT use & dosing before & after worsenin…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…
We continue to fail our failure patients 🤦🏻♂️
RT @SJGreene_md: Outstanding study in @JACCJournals by @JavedButler1 and team. In real-world practice, major gaps in use of evidence-based…